Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
American Journal of Clinical Oncology|November 5, 1997
Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU)J Nemunaitis, J Cox, W Meyer, et al.
Gene Therapy|February 15, 2001
Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude miceY A Zhang, J Nemunaitis, K J Scanlon, et al.
Blood|June 15, 1990
Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40J L Slack, J Nemunaitis, D F Andrews, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2001
Toxicity assessment of intratumoral injection of the herpes simplex type I thymidine kinase gene delivered by retrovirus in patients with refractory cancerS Singh, C Cunningham, A Buchanan, et al.
European Journal of Haematology|March 1, 1991
Transforming growth factor beta expression in human marrow stromal cellsJ Nemunaitis, C K Tompkins, D F Andrews, et al.
Cancer Letters|January 18, 2015
Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in miceJames X Wu, Shi-He Liu, John J Nemunaitis, et al.
Clinical Lung Cancer|January 1, 2004
Potential clinical application of antioncogene ribozymes for human lung cancerA W Tong, Y A Zhang, C Cunningham, et al.
Oncology (Williston Park, N.Y.)|April 17, 2001
Gene therapy for head and neck cancersJ P Lamont, J A Kuhn, J J Nemunaitis, et al.
Leukemia & Lymphoma|June 1, 1993
rhGM-CSF after allogeneic bone marrow transplantation from unrelated donors: a pilot study of cyclosporine and prednisone as graft-versus-host disease prophylaxisJ Nemunaitis, C Anasetti, J A Bianco, et al.
The Journal of Clinical Investigation|February 1, 1989
Response of simian virus 40 (SV40)-transformed, cultured human marrow stromal cells to hematopoietic growth factorsJ Nemunaitis, D F Andrews, C Crittenden, et al.
Pageof 17